REVVITY, INC Gain (Loss) on Disposition of Assets
REVVITY, INC (RVTY) reported Gain (Loss) on Disposition of Assets of -$5.07 million for the 3-month period ending 2026-04-05, per its 10-Q filed 2026-05-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-05-12
- REVVITY, INC gain (loss) on disposition of assets for the quarter ending 2026-04-05 was -$5.07M.
- REVVITY, INC gain (loss) on disposition of assets for the quarter ending 2025-03-30 was $0.00.
- REVVITY, INC gain (loss) on disposition of assets for the quarter ending 2016-10-02 was -$1.55M.
- REVVITY, INC gain (loss) on disposition of assets for the quarter ending 2016-07-03 was -$1.55M.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month |
|---|---|---|
| 2026-04-05 | -$5.07M 10-Q · filed 2026-05-12 | |
| 2025-03-30 | $0.00 10-Q · filed 2026-05-12 | |
| 2016-10-02 | -$1.55M 10-Q · filed 2016-11-08 | -$3.11M derived: sum of 2 quarters · filed 2016-11-08 |
| 2016-07-03 | -$1.55M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |